Pharmacosmos settles legal dispute with Vifor
Pharmacosmos is now withdrawing the press release that the Danish Medicines Agency has ruled was in breach of the Danish Medicines Act. The ruling was the root of the subsequent case which competitor Vifor brought against the company in the Maritime and Commercial High Court of Denmark.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL PEDERSEN
Approximately two years have passed since the conflict between the Danish company Pharmacosmos and Vifor Pharma, which is based in Switzerland, began over a phosphare study. The conflict is now solved in a settlement in the Maritime and Commercial High Court of Denmark.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pharmacosmos launches cell therapy market offensive
For subscribers
Vifor Pharma gets new CEO
For subscribers
